Manufacturer: INTAS
Pharmaceutical name: Etizolam
Pack: 100 pills (0.5 mg)
Etilaam MD is a medication belonging to the thienobenzodiazepine class, containing Etizolam. It functions as an anxiolytic, sedative-hypnotic, and antidepressant. Etilaam MD is prescribed for oral administration to treat anxiety disorders, including panic attacks and generalized anxiety, as well as depression in adult patients. It is also beneficial for the short-term management of insomnia. Additionally, Etilaam MD acts as an anti-convulsant, helping to relax skeletal muscles and address various medical issues. It selectively targets and has a strong affinity for the alpha2 subunit of the postsynaptic GABA receptor.
Etilaam MD contains Etizolam, which emulates anti-convulsant properties. It is administered to patients for short-term insomnia treatment and is effective for managing situational anxiety, such as panic attacks and phobic neurosis. Etilaam MD tablets are utilized in treating secondary psychosomatic conditions, including headaches, irritable bowel syndrome (IBS), and hypertension.
The maximum daily dosage of Etilaam MD should not exceed 3 mg. For anxiety disorders, the recommended dosage is 0.25-0.5 mg of Etizolam taken twice daily. For panic disorders, a suggested dosage is 0.5 mg twice daily. For patients experiencing insomnia (difficulty sleeping), doctors often recommend a dosage of 1-2 mg of Etizolam before bedtime.
A treatment regimen involving Etilaam MD should not last more than 12 weeks. It is important not to stop taking Etilaam MD without guidance from a healthcare professional. Discontinuing Etilaam MD should not be done abruptly; instead, the dosage should be gradually reduced to prevent any potential withdrawal symptoms.
Cardiovascular System: decreased heart rate, hypotension, bradycardia. Central Nervous System: drowsiness, sedation, ataxia, vertigo, headache, confusion, depression, slurred speech, coma. Eye and ENT: visual disturbances, involuntary eye movement, and eyelid closure. Gastrointestinal System: alterations in salivation, nausea, vomiting, dry mouth. Genitourinary System: changes in libido, urinary retention, gastrointestinal disturbances. Musculoskeletal System: muscle weakness, muscle relaxation. General: amnesia, reduced appetite, respiratory depression.